TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Psoriasis Treatment Drugs Market Research Report 2022

Global Psoriasis Treatment Drugs Market Research Report 2022

  • Category:Life Sciences
  • Published on : 24 October 2022
  • Pages :100
  • Formats:
  • Report Code:SMR-7459290
OfferClick for best price

Best Price: $2320

Psoriasis Treatment Drugs Market Size, Share 2022


Market Analysis and Insights: Global Psoriasis Treatment Drugs Market

The global Psoriasis Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Psoriasis Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Psoriasis Treatment Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Psoriasis Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Psoriasis Treatment Drugs market.

Global Psoriasis Treatment Drugs Scope and Market Size

Psoriasis Treatment Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Psoriasis Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

TNF Inhibitors

Interleukin Inhibitors

Vitamin D Analogs

Corticosteroids

Others

Segment by Application

Oral

Parenteral

Topical

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Amgen

Allergan

Dermira

Eli Lilly

Novartis

Merck

Johnson & Johnson

Pfizer

AstraZeneca

AbbVie

LEO Pharma

Biogen

Galectin Therapeutics

Cellceutix

Bayer

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Psoriasis Treatment Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Psoriasis Treatment Drugs, with price, sales, revenue, and global market share of Psoriasis Treatment Drugs from 2019 to 2022.

Chapter 3, the Psoriasis Treatment Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Psoriasis Treatment Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Psoriasis Treatment Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Psoriasis Treatment Drugs.

Chapter 13, 14, and 15, to describe Psoriasis Treatment Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Psoriasis Treatment Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Psoriasis Treatment Drugs Market Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 100 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Treatment Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 TNF Inhibitors
1.2.3 Interleukin Inhibitors
1.2.4 Vitamin D Analogs
1.2.5 Corticosteroids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Psoriasis Treatment Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Treatment Drugs Market Perspective (2017-2028)
2.2 Psoriasis Treatment Drugs Growth Trends by Region
2.2.1 Psoriasis Treatment Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Psoriasis Treatment Drugs Historic Market Size by Region (2017-2022)
2.2.3 Psoriasis Treatment Drugs Forecasted Market Size by Region (2023-2028)
2.3 Psoriasis Treatment Drugs Market Dynamics
2.3.1 Psoriasis Treatment Drugs Industry Trends
2.3.2 Psoriasis Treatment Drugs Market Drivers
2.3.3 Psoriasis Treatment Drugs Market Challenges
2.3.4 Psoriasis Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Treatment Drugs Players by Revenue
3.1.1 Global Top Psoriasis Treatment Drugs Players by Revenue (2017-2022)
3.1.2 Global Psoriasis Treatment Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Psoriasis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psoriasis Treatment Drugs Revenue
3.4 Global Psoriasis Treatment Drugs Market Concentration Ratio
3.4.1 Global Psoriasis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Treatment Drugs Revenue in 2021
3.5 Psoriasis Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Psoriasis Treatment Drugs Product Solution and Service
3.7 Date of Enter into Psoriasis Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Treatment Drugs Breakdown Data by Type
4.1 Global Psoriasis Treatment Drugs Historic Market Size by Type (2017-2022)
4.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2023-2028)
5 Psoriasis Treatment Drugs Breakdown Data by Application
5.1 Global Psoriasis Treatment Drugs Historic Market Size by Application (2017-2022)
5.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Psoriasis Treatment Drugs Market Size (2017-2028)
6.2 North America Psoriasis Treatment Drugs Market Size by Country (2017-2022)
6.3 North America Psoriasis Treatment Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Psoriasis Treatment Drugs Market Size (2017-2028)
7.2 Europe Psoriasis Treatment Drugs Market Size by Country (2017-2022)
7.3 Europe Psoriasis Treatment Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriasis Treatment Drugs Market Size (2017-2028)
8.2 Asia-Pacific Psoriasis Treatment Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Psoriasis Treatment Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Psoriasis Treatment Drugs Market Size (2017-2028)
9.2 Latin America Psoriasis Treatment Drugs Market Size by Country (2017-2022)
9.3 Latin America Psoriasis Treatment Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriasis Treatment Drugs Market Size (2017-2028)
10.2 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Psoriasis Treatment Drugs Introduction
11.1.4 Amgen Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.1.5 Amgen Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Psoriasis Treatment Drugs Introduction
11.2.4 Allergan Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.2.5 Allergan Recent Development
11.3 Dermira
11.3.1 Dermira Company Detail
11.3.2 Dermira Business Overview
11.3.3 Dermira Psoriasis Treatment Drugs Introduction
11.3.4 Dermira Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.3.5 Dermira Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Psoriasis Treatment Drugs Introduction
11.4.4 Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.4.5 Eli Lilly Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Psoriasis Treatment Drugs Introduction
11.5.4 Novartis Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.5.5 Novartis Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Psoriasis Treatment Drugs Introduction
11.6.4 Merck Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.6.5 Merck Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Psoriasis Treatment Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.7.5 Johnson & Johnson Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Psoriasis Treatment Drugs Introduction
11.8.4 Pfizer Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.8.5 Pfizer Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Psoriasis Treatment Drugs Introduction
11.9.4 AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.9.5 AstraZeneca Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Psoriasis Treatment Drugs Introduction
11.10.4 AbbVie Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.10.5 AbbVie Recent Development
11.11 LEO Pharma
11.11.1 LEO Pharma Company Detail
11.11.2 LEO Pharma Business Overview
11.11.3 LEO Pharma Psoriasis Treatment Drugs Introduction
11.11.4 LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.11.5 LEO Pharma Recent Development
11.12 Biogen
11.12.1 Biogen Company Detail
11.12.2 Biogen Business Overview
11.12.3 Biogen Psoriasis Treatment Drugs Introduction
11.12.4 Biogen Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.12.5 Biogen Recent Development
11.13 Galectin Therapeutics
11.13.1 Galectin Therapeutics Company Detail
11.13.2 Galectin Therapeutics Business Overview
11.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Introduction
11.13.4 Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.13.5 Galectin Therapeutics Recent Development
11.14 Cellceutix
11.14.1 Cellceutix Company Detail
11.14.2 Cellceutix Business Overview
11.14.3 Cellceutix Psoriasis Treatment Drugs Introduction
11.14.4 Cellceutix Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.14.5 Cellceutix Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Psoriasis Treatment Drugs Introduction
11.15.4 Bayer Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.15.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Psoriasis Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of TNF Inhibitors
Table 3. Key Players of Interleukin Inhibitors
Table 4. Key Players of Vitamin D Analogs
Table 5. Key Players of Corticosteroids
Table 6. Key Players of Others
Table 7. Global Psoriasis Treatment Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Psoriasis Treatment Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Psoriasis Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Psoriasis Treatment Drugs Market Share by Region (2017-2022)
Table 11. Global Psoriasis Treatment Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Psoriasis Treatment Drugs Market Share by Region (2023-2028)
Table 13. Psoriasis Treatment Drugs Market Trends
Table 14. Psoriasis Treatment Drugs Market Drivers
Table 15. Psoriasis Treatment Drugs Market Challenges
Table 16. Psoriasis Treatment Drugs Market Restraints
Table 17. Global Psoriasis Treatment Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Psoriasis Treatment Drugs Market Share by Players (2017-2022)
Table 19. Global Top Psoriasis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Treatment Drugs as of 2021)
Table 20. Ranking of Global Top Psoriasis Treatment Drugs Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Psoriasis Treatment Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Psoriasis Treatment Drugs Product Solution and Service
Table 24. Date of Enter into Psoriasis Treatment Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Psoriasis Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Psoriasis Treatment Drugs Revenue Market Share by Type (2017-2022)
Table 28. Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Psoriasis Treatment Drugs Revenue Market Share by Type (2023-2028)
Table 30. Global Psoriasis Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Psoriasis Treatment Drugs Revenue Market Share by Application (2017-2022)
Table 32. Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Psoriasis Treatment Drugs Revenue Market Share by Application (2023-2028)
Table 34. North America Psoriasis Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Psoriasis Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Psoriasis Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Psoriasis Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Psoriasis Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Psoriasis Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Amgen Company Detail
Table 45. Amgen Business Overview
Table 46. Amgen Psoriasis Treatment Drugs Product
Table 47. Amgen Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 48. Amgen Recent Development
Table 49. Allergan Company Detail
Table 50. Allergan Business Overview
Table 51. Allergan Psoriasis Treatment Drugs Product
Table 52. Allergan Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 53. Allergan Recent Development
Table 54. Dermira Company Detail
Table 55. Dermira Business Overview
Table 56. Dermira Psoriasis Treatment Drugs Product
Table 57. Dermira Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 58. Dermira Recent Development
Table 59. Eli Lilly Company Detail
Table 60. Eli Lilly Business Overview
Table 61. Eli Lilly Psoriasis Treatment Drugs Product
Table 62. Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 63. Eli Lilly Recent Development
Table 64. Novartis Company Detail
Table 65. Novartis Business Overview
Table 66. Novartis Psoriasis Treatment Drugs Product
Table 67. Novartis Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Merck Company Detail
Table 70. Merck Business Overview
Table 71. Merck Psoriasis Treatment Drugs Product
Table 72. Merck Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 73. Merck Recent Development
Table 74. Johnson & Johnson Company Detail
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Psoriasis Treatment Drugs Product
Table 77. Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. Pfizer Company Detail
Table 80. Pfizer Business Overview
Table 81. Pfizer Psoriasis Treatment Drugs Product
Table 82. Pfizer Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. AstraZeneca Company Detail
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Psoriasis Treatment Drugs Product
Table 87. AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. AbbVie Company Detail
Table 90. AbbVie Business Overview
Table 91. AbbVie Psoriasis Treatment Drugs Product
Table 92. AbbVie Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 93. AbbVie Recent Development
Table 94. LEO Pharma Company Detail
Table 95. LEO Pharma Business Overview
Table 96. LEO Pharma Psoriasis Treatment DrugsProduct
Table 97. LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 98. LEO Pharma Recent Development
Table 99. Biogen Company Detail
Table 100. Biogen Business Overview
Table 101. Biogen Psoriasis Treatment DrugsProduct
Table 102. Biogen Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 103. Biogen Recent Development
Table 104. Galectin Therapeutics Company Detail
Table 105. Galectin Therapeutics Business Overview
Table 106. Galectin Therapeutics Psoriasis Treatment DrugsProduct
Table 107. Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 108. Galectin Therapeutics Recent Development
Table 109. Cellceutix Company Detail
Table 110. Cellceutix Business Overview
Table 111. Cellceutix Psoriasis Treatment DrugsProduct
Table 112. Cellceutix Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 113. Cellceutix Recent Development
Table 114. Bayer Company Detail
Table 115. Bayer Business Overview
Table 116. Bayer Psoriasis Treatment DrugsProduct
Table 117. Bayer Revenue in Psoriasis Treatment Drugs Business (2017-2022) & (US$ Million)
Table 118. Bayer Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psoriasis Treatment Drugs Market Share by Type: 2021 VS 2028
Figure 2. TNF Inhibitors Features
Figure 3. Interleukin Inhibitors Features
Figure 4. Vitamin D Analogs Features
Figure 5. Corticosteroids Features
Figure 6. Others Features
Figure 7. Global Psoriasis Treatment Drugs Market Share by Application in 2021 & 2028
Figure 8. Oral Case Studies
Figure 9. Parenteral Case Studies
Figure 10. Topical Case Studies
Figure 11. Psoriasis Treatment Drugs Report Years Considered
Figure 12. Global Psoriasis Treatment Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Psoriasis Treatment Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Psoriasis Treatment Drugs Market Share by Region: 2021 VS 2028
Figure 15. Global Psoriasis Treatment Drugs Market Share by Players in 2021
Figure 16. Global Top Psoriasis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Treatment Drugs as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Psoriasis Treatment Drugs Revenue in 2021
Figure 18. North America Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Psoriasis Treatment Drugs Market Share by Country (2017-2028)
Figure 20. United States Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Psoriasis Treatment Drugs Market Share by Country (2017-2028)
Figure 24. Germany Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Psoriasis Treatment Drugs Market Share by Region (2017-2028)
Figure 32. China Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Psoriasis Treatment Drugs Market Share by Country (2017-2028)
Figure 40. Mexico Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Psoriasis Treatment Drugs Market Share by Country (2017-2028)
Figure 44. Turkey Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Psoriasis Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Amgen Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 47. Allergan Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 48. Dermira Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 49. Eli Lilly Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 50. Novartis Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 51. Merck Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 52. Johnson & Johnson Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 53. Pfizer Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 54. AstraZeneca Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 55. AbbVie Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 56. LEO Pharma Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 57. Biogen Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 58. Galectin Therapeutics Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 59. Cellceutix Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 60. Bayer Revenue Growth Rate in Psoriasis Treatment Drugs Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount